GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock Shanghai S.E.
Equities
600332
CNE000001733
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.54 CNY | +2.74% |
|
+10.24% | +10.28% |
| Sales 2024 * | 80.8B 11.16B | Sales 2025 * | 85.61B 11.82B | Capitalization | 48.48B 6.7B |
|---|---|---|---|---|---|
| Net income 2024 * | 4.17B 577M | Net income 2025 * | 4.44B 613M | EV / Sales 2024 * | 0.36 x |
| Net cash position 2024 * | 19.18B 2.65B | Net cash position 2025 * | 22.46B 3.1B | EV / Sales 2025 * | 0.3 x |
| P/E ratio 2024 * |
7.55
x | P/E ratio 2025 * |
7.26
x | Employees | 28,048 |
| Yield 2024 * |
4.28% | Yield 2025 * |
4.54% | Free-Float | 49.33% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.74% | ||
| 1 week | +10.24% | ||
| Current month | +9.32% | ||
| 1 month | +8.42% | ||
| 3 months | +14.65% | ||
| 6 months | +9.67% | ||
| Current year | +10.28% |
1 week
28.62
31.61
1 month
28.2231.61
Current year
26.5031.61
1 year
26.5037.09
3 years
25.3237.20
5 years
25.3245.88
10 years
19.6048.46
| Managers | Title | Age | Since |
|---|---|---|---|
Hong Li
CEO | Chief Executive Officer | 57 | 17-06-22 |
Rui Yu Cai
CHM | Chairman | 57 | - |
Chun Bo Zhang
BRD | Director/Board Member | 47 | 14-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Lung Tak Wong
BRD | Director/Board Member | 76 | 10-06-27 |
Ju Yan Liu
BRD | Director/Board Member | 59 | 13-11-30 |
Hong Li
CEO | Chief Executive Officer | 57 | 17-06-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.72% | 2 M€ | -20.87% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 31.54 | +2.74% | 17,208,600 |
| 24-04-18 | 30.7 | +1.22% | 14,583,420 |
| 24-04-17 | 30.33 | +1.44% | 11,322,470 |
| 24-04-16 | 29.9 | +1.77% | 16,155,430 |
| 24-04-15 | 29.38 | +2.69% | 11,234,600 |
End-of-day quote Shanghai S.E., April 18, 2024
More quotes
Guangzhou Baiyunshan Pharmaceutical Holding Co., Ltd. specializes in researching, developing and manufacturing pharmaceutical products. The group's products include analgesics, antibiotics, medicines for the treatment of stomach disorders, treatment of cough, antitoxic products, etc.
Sector
Pharmaceuticals
Calendar
2024-04-26
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
18.81
CNY
Average target price
22.06
CNY
Spread / Average Target
+17.30%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +24.60% | 654B | |
| +24.08% | 552B | |
| -5.63% | 356B | |
| +15.37% | 319B | |
| +7.38% | 295B | |
| +3.26% | 211B | |
| +0.78% | 206B | |
| -9.16% | 197B | |
| -9.69% | 147B |
- Stock Market
- Equities
- 874 Stock
- 600332 Stock
